Description and Brand Names
Información sobre medicamentos proporcionada por: IBM Micromedex
US Brand Name
Zanubrutinib is used to treat mantle cell lymphoma (MCL) in adults who have received at least one previous treatment for their cancer. This medicine is also used to treat Waldenström macroglobulinemia (WM). It is also used to treat marginal zone lymphoma (MZL) that has come back (relapsed) or did not respond to the treatment (refractory) in patients who have received at least one previous treatment (eg, anti-CD20-based treatment). It interferes with the growth of cancer cells, which are eventually destroyed by the body. Zanubrutinib is an antineoplastic agent (cancer medicine).
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms: